Zurcher Kantonalbank Finance (Guernsey) Limited Share Price

Certificat

Z0915Z

CH1303992296

Market Closed - Swiss Exchange 08:50:00 24/06/2024 pm IST
98.99 EUR +0.33% Intraday chart for Zurcher Kantonalbank Finance (Guernsey) Limited
1 month-0.12%
3 months-0.40%

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying NOVARTIS AG
Issuer ZKB
Z0915Z
ISINCH1303992296
Date issued 01/02/2024
Strike 90.54 CHF
Maturity 03/02/2025 (215 Days)
Parity 1 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 100.2
Lowest since issue 95.65
Spread 7
Spread %0.70%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
106.7 USD
Average target price
110.3 USD
Spread / Average Target
+3.41%
Consensus
  1. Stock Market
  2. Certificates
  3. Z0915Z Certificat